Literature DB >> 23352227

mTOR, linking metabolism and immunity.

Xiaojin Xu1, Lilin Ye, Koichi Araki, Rafi Ahmed.   

Abstract

mTOR is an evolutionarily conserved serine/threonine kinase that plays a critical role in cell growth and metabolism by sensing different environmental cues. There is a growing appreciation of mTOR in immunology for its role in integrating diverse signals from the immune microenvironment and coordinating the functions of immune cells and their metabolism. In CD8 T cells, mTOR has shown to influence cellular commitment to effector versus memory programming; in CD4 T cells, mTOR integrates environmental cues that instruct effector cell differentiation. In this review, we summarize and discuss recent advances in the field, with a focus on the mechanisms through which mTOR regulates cellular and humoral immunity. Further understanding will enable the manipulation of mTOR signaling to direct the biological functions of immune cells, which holds great potential for improving immune therapies and vaccination against infections and cancer.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23352227      PMCID: PMC3582734          DOI: 10.1016/j.smim.2012.12.005

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  75 in total

Review 1.  Germinal centers.

Authors:  Gabriel D Victora; Michel C Nussenzweig
Journal:  Annu Rev Immunol       Date:  2012-01-03       Impact factor: 28.527

Review 2.  mTOR signaling in growth control and disease.

Authors:  Mathieu Laplante; David M Sabatini
Journal:  Cell       Date:  2012-04-13       Impact factor: 41.582

Review 3.  mTOR signaling in disease.

Authors:  Eva Dazert; Michael N Hall
Journal:  Curr Opin Cell Biol       Date:  2011-09-29       Impact factor: 8.382

Review 4.  The influence of mTOR on T helper cell differentiation and dendritic cell function.

Authors:  Robert J Salmond; Rose Zamoyska
Journal:  Eur J Immunol       Date:  2011-07-04       Impact factor: 5.532

5.  Direct activation of mTOR in B lymphocytes confers impairment in B-cell maturation andloss of marginal zone B cells.

Authors:  Sandrine Benhamron; Boaz Tirosh
Journal:  Eur J Immunol       Date:  2011-06-24       Impact factor: 5.532

Review 6.  TOR in the immune system.

Authors:  Koichi Araki; Ali H Ellebedy; Rafi Ahmed
Journal:  Curr Opin Cell Biol       Date:  2011-09-16       Impact factor: 8.382

Review 7.  Regulation of immune responses by mTOR.

Authors:  Jonathan D Powell; Kristen N Pollizzi; Emily B Heikamp; Maureen R Horton
Journal:  Annu Rev Immunol       Date:  2011-11-29       Impact factor: 28.527

8.  Estrogen-related receptor-α is a metabolic regulator of effector T-cell activation and differentiation.

Authors:  Ryan D Michalek; Valerie A Gerriets; Amanda G Nichols; Makoto Inoue; Dmitri Kazmin; Ching-Yi Chang; Mary A Dwyer; Erik R Nelson; Kristen N Pollizzi; Olga Ilkayeva; Vincent Giguere; William J Zuercher; Jonathan D Powell; Mari L Shinohara; Donald P McDonnell; Jeffrey C Rathmell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-31       Impact factor: 11.205

9.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

Authors:  Ruoning Wang; Christopher P Dillon; Lewis Zhichang Shi; Sandra Milasta; Robert Carter; David Finkelstein; Laura L McCormick; Patrick Fitzgerald; Hongbo Chi; Joshua Munger; Douglas R Green
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

Review 10.  Regulatory T cells: mechanisms of differentiation and function.

Authors:  Steven Z Josefowicz; Li-Fan Lu; Alexander Y Rudensky
Journal:  Annu Rev Immunol       Date:  2012-01-06       Impact factor: 28.527

View more
  39 in total

1.  The cell identity of cytotoxic T lymphocytes.

Authors:  David E Sanin; Edward J Pearce
Journal:  Nat Immunol       Date:  2016-01       Impact factor: 25.606

2.  Thymic emigration patterns in patients with type 2 diabetes treated with metformin.

Authors:  Grzegorz Dworacki; Olzhas Urazayev; Yerbol Bekmukhambetov; Saule Iskakova; Bartosz A Frycz; Paweł P Jagodziński; Marzena Dworacka
Journal:  Immunology       Date:  2015-10-05       Impact factor: 7.397

Review 3.  Optimization of immunosuppressive medication upon liver transplantation against HCC recurrence.

Authors:  Shirin Elizabeth Khorsandi; Nigel Heaton
Journal:  Transl Gastroenterol Hepatol       Date:  2016-04-06

4.  Two insulin-like peptides differentially regulate malaria parasite infection in the mosquito through effects on intermediary metabolism.

Authors:  Jose E Pietri; Nazzy Pakpour; Eleonora Napoli; Gyu Song; Eduardo Pietri; Rashaun Potts; Kong W Cheung; Gregory Walker; Michael A Riehle; Hannah Starcevich; Cecilia Giulivi; Edwin E Lewis; Shirley Luckhart
Journal:  Biochem J       Date:  2016-08-05       Impact factor: 3.857

5.  B Cell-Specific Biomarkers for Optimal Antibody Responses to Influenza Vaccination and Molecular Pathways That Reduce B Cell Function with Aging.

Authors:  Daniela Frasca; Bonnie B Blomberg
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

6.  B cell-specific deficiencies in mTOR limit humoral immune responses.

Authors:  Shuling Zhang; Margaret Pruitt; Dena Tran; Wendy Du Bois; Ke Zhang; Rushi Patel; Shelley Hoover; R Mark Simpson; John Simmons; Joy Gary; Clifford M Snapper; Rafael Casellas; Beverly A Mock
Journal:  J Immunol       Date:  2013-07-15       Impact factor: 5.422

Review 7.  Beyond adjuvants: immunomodulation strategies to enhance T cell immunity.

Authors:  Alice O Kamphorst; Koichi Araki; Rafi Ahmed
Journal:  Vaccine       Date:  2015-06-08       Impact factor: 3.641

8.  Mammalian target of rapamycin complex 1 signalling is essential for germinal centre reaction.

Authors:  Bingshou Li; Zhirong Li; Pengcheng Wang; Qizhao Huang; Lifan Xu; Ran He; Lilin Ye; Qiang Bai
Journal:  Immunology       Date:  2017-07-10       Impact factor: 7.397

Review 9.  Intersection of mTOR and STAT signaling in immunity.

Authors:  Diana Saleiro; Leonidas C Platanias
Journal:  Trends Immunol       Date:  2014-11-15       Impact factor: 16.687

Review 10.  Rapamycin-resistant effector T-cell therapy.

Authors:  Daniel H Fowler
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.